文献速递浆细胞疾病

多发性骨髓瘤及其他浆细胞疾病的饮食与微生物组证据

Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders.
PubMed 文献 · Leukemia · 2023-03-30

本文综述了饮食和肠道微生物组因素在多发性骨髓瘤(MM)发病机制中的作用及其对结局的影响。文章指出肥胖、糖尿病、饮食和人类肠道微生物组等代谢危险因素与MM发病相关,并汇总了饮食及其他生活方式干预对肠道微生物组及MM发病率、结局和生活质量影响的现有证据。

要点

  • 肥胖、糖尿病、饮食和肠道微生物组等代谢因素与MM发病相关。
  • 饮食及其他生活方式干预可能影响肠道微生物组及MM发病率、结局和生活质量。
  • 现有证据可用于为高风险个体(如MGUS和SMM)及MM幸存者提供饮食建议。

核心结论

  • 饮食和微生物组因素参与MM发病并可能影响结局,相关证据可帮助制定基于证据的饮食指南。

研究设计与样本

  • 本文为综述,检索范围未在摘要中具体说明。

主要发现

  • 肥胖、糖尿病、饮食和人类肠道微生物组等代谢危险因素与MM发病机制相关。
  • 饮食及其他生活方式干预对肠道微生物组及MM发病率、结局和生活质量的影响已有证据汇总。

关键数值与推荐

  • 原文未报告具体数值标准。

临床怎么用

  • 作者认为现有证据可帮助医疗提供者为高风险个体(如MGUS和SMM)及MM幸存者提供饮食建议。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Multiple Myeloma (MM) remains an incurable plasma cell neoplasm. Although little is known about the etiology of MM, several metabolic risk factors such as obesity, diabetes mellitus, diet, and the human intestinal microbiome have been linked to the pathogenesis of MM. In this article, we provide a detailed review of dietary and microbiome factors involved in the pathogenesis of MM and their impact on outcomes. Concurrent with treatment advancements that have improved survival in MM, focused efforts are needed to reduce the burden of MM as well as improve MM specific and overall outcomes once MM is diagnosed. The findings presented in this review will provide a comprehensive guide on the evidence available to date of the impact of dietary and other lifestyle interventions on the gut microbiome and on MM incidence, outcomes, and quality of life. Data generated from such studies can help formulate evidence-based guidelines for healthcare providers to counsel individuals at risk such as those with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) as well as MM survivors with respect to their dietary habits.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Shah UA, Parikh R, Castro F, et al. Dietary and microbiome evidence in multiple myeloma and other plasma cell disorders. Leukemia. 2023. PMID: 36997677. doi:10.1038/s41375-023-01874-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。